TripleBlind raises $24M Series A co-led by Mayo Clinic Kansas City, MO

The round was led by The Reinalt-Thomas Corporation, the major tire retail brand behind Discount Tire and America’s Tire. Electric truck maker Rivianfiled paperwork to go public milford barber shop andis expected to be the largest IPO of the year. Rivian’s IPO is expected to round out a number of IPO and SPAC deals from electric vehicle companies over the past year or so.

The company’s technology enables the highest resolution and smallest form factor wavelength infrared sensors for key industrial, defense and emerging large market applications. US – Data sharing company TripleBlind has received $24m in a Series A funding round led by General Catalyst and Mayo Clinic. More specifically, “We struggled with accessing data to improve our models and the precision of the service,” he said. TripleBlind is collaborating with Mayo on data analysis, algorithm training and validation on one-way encrypted data and on next-generation…Read more on TripleBlinddeveloped a way to encrypt data so they can be shared without being decrypted or leaving the data owner’s firewall.

To realize this, digital formularies will be required for efficient workflow62. A multi-health system company collaborative called Graphite Health aims to provide such a formulary, while also promoting a development environment and marketplace that offers digital health products interoperable across different health systems63. Large medical centers that incorporated digital health solutions into clinical operations mainly focused on telemedicine, and to a lesser extent, RPM17. Before the pandemic, most leading telemedicine programs produced small absolute telemedicine visit volumes compared to traditional in-person encounters, which generally mirrored national telemedicine trends18. Select large integrated health systems, such as Kaiser Permanente, however, reported using telehealth for over half of its 2015 visit volume19,20.

Institutions wrestled with integration into the EHR, use and value of data, impact on clinical workflow, and outcome metrics. In telemedicine, for example, there were payer limitations on “originating sites,” structural limitations against audio-only interactions, severely truncated visit type allowances, and a lack of payer parity when comparing digital (e.g. telemedicine virtual visits) and conventional offerings. Despite more than a decade of intense digital health industry growth, investment, and advocacy, these limitations remained largely fixed until the early months of 2020. The present systematic review, unlike the previous ones including studies on locally administered statins and/or on systemic statins as adjuncts to periodontal treatment , aimed to primarily evaluate the putative positive effect on untreated periodontitis and peri-implantitis of systemic statin therapy (≥1 month) alone.

Impactful digital health solutions that enable such data exchange will lead to changes in management, provide useful patient insights, and begin to augment or even replace traditional history taking. These technologies should enable the collection of “digital outcome measures,” the “digital examination,” and even the “digital history”54,55. Examples of such technologies enable clinically-relevant data collection targeting specific diseases like hypertension, inflammatory bowel disease, COPD, and CHF54,56–58. Beyond basic audio-video televisits, there exist various advanced telemedicine techniques that exploit the digital interface. For example, asynchronous and real-time ophthalmic assessment has enabled providers to successfully capture and assess fundus imagery for triage and disease screening and management59. Other remote ophthalmic assessment approaches, such as digital home visual acuity and Amsler grid testing, may be equal or superior to the comparable traditional means59,60.

Radiographic periodontal parameters around natural teeth were not recorded nor reported in any of the included studies, even if bone loss may be positively affected by statin use, which has been hypothesized to reduce the risk of fracture and increase bone density . Although many large medical centers began to invest in digital health companies, and create “innovation hubs” to co-develop, invest in, or spin-out companies, few scaled digital health experiences and expertise across clinical operations8–11. In the pre-COVID-19 period, clinical adoption was primarily driven by financially incentivizing models.

These institutions, which may provide primary and general care to large local populations, and tertiary level care across a much larger geographic region, often must tailor solutions to these two prongs of care with consideration of patients’ social drivers of health. Further, the potential solutions must meet key tenants of adoption, many of which have been outlined by Marwaha et al and others1,47,48. Attention to these tenants ensures patients can access, understand, use, and benefit from the technologies, including marginalized, lower socioeconomic, or older populations. RPM also expanded and included COVID-19-specific home-based monitoring such as text message check-ins, temperature monitoring, and oxygen saturation assessments, digitally transmitted to clinical monitoring centers34,35. RPM programs at institutions such as Mayo Clinic, Intermountain, University of Colorado, and Brigham and Women’s Hospital also expanded36–39. Some expansion efforts in virtual care combined RPM with virtual visits, virtual rehabilitation, and patient coaching.

This new partnership will allow Deck Commerce to enhance its product offering to feature more direct-to-consumer capabilities for leading brands. TripleBlind’s platform, which officially launched in November 2020, is compliant today with data privacy and data residency regulations in some 100 countries, HIPAA, GDPR and California’s CCPA among them. The company estimates there are some 43 zetabytes of data stored by enterprises today globally that is not being used as it could be because of the limitations imposed both by these and other data protection rules, as well as general hesitancy over sharing IP and other issues around sharing data. It works with data in a variety of formats, including PII, PHI, genomic data, images and confidential financial records. As Mayo Clinic builds a suite of clinical tools based on patient data, it’s looking to new solutions to manage that data.